Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. May 15, 2024; 16(5): 1796-1807
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1796
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1796
Table 1 Comparison of baseline data of rectal carcinoma patients with different T stages
Factors | Low stage group (n = 62) | High stage group (n = 42) | P value |
Age (yr) | 0.474 | ||
≥ 60 | 34 | 26 | |
< 60 | 28 | 16 | |
Sex | 0.636 | ||
Male | 34 | 25 | |
Female | 28 | 17 | |
BMI (kg/m2) | 0.755 | ||
≥ 25 | 16 | 12 | |
< 25 | 46 | 30 | |
Tumor site | 0.991 | ||
Upper | 21 | 14 | |
Middle | 17 | 12 | |
Lower | 24 | 16 | |
Tumor type | 0.854 | ||
Protruded | 8 | 7 | |
Ulcerative | 44 | 29 | |
Infiltrating | 10 | 6 | |
Differentiation degree | 0.786 | ||
Moderate-high differentiation | 40 | 26 | |
Low differentiation | 22 | 16 |
- Citation: Mu RQ, Lv JW, Ma CY, Ma XH, Xing D, Ma HS. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging parameters and serum tumor markers in rectal carcinoma prognosis. World J Gastrointest Oncol 2024; 16(5): 1796-1807
- URL: https://www.wjgnet.com/1948-5204/full/v16/i5/1796.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i5.1796